Shionogi & Co.,Ltd. (4507) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-09-16 | — | COVGOZE for Intramuscular Injection (JN.1-adapted), Recombinant Protein COVID-19 Vaccine, Receives Partial Change Approval in Japan | |
| 2026-09-16 | — | Notice Regarding Approval of an Additional Dosage and Administration of VTAMA Cream for Pediatric Atopic Dermatitis (Under Age12) in Japan | |
| 2026-08-03 | Earnings Release | Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS) | |
| 2026-08-03 | Earnings Release | Financial Results for the 1st Quarter of FY2026 Supplement | |
| 2026-08-03 | Earnings Release | 1st Quarter of Fiscal 2026 Financial Resultsand HIVBusiness Update | |
| 2026-07-23 | Treasury Shares | Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.